Hemab Therapeutics Holdings, Inc. COAG
38.76 USD -4.05 (-9.46%)
Nov 10, 2026, 3:59 PM EST
36.57 Day range 44.15
23.00 52-week range 55.42
- YTD
- +14.00%
- 1 year
- +14.00%
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 |
|---|---|---|
| -70.12M | -50.38M | |
| -63.91M | -48.71M | |
| -67.56 | -51.49 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 |
|---|---|---|
| 87.97M | 74.41M | |
| 194.78M | 96.28M | |
| 11.25M | 7.80M | |
| 1.22M | 1.73M | |
| -176.63M | -115.27M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 |
|---|---|---|
| -61.48M | -45.59M | |
| -81.48M | 61.90M | |
| 156.30M | -100.00K | |
| -16.00K | -282.00K | |
| 13.57M | 16.21M |